- Abotaleb, N., Pazouki, H., Homayoon, H. and Nouri, J. (1389). Simvastatin-induced renal protection against ischemia reperfusion injury mediated by activation of ATP-sensitive potassium channels. Razi Journal of Medical Sciences, 71(7): 7-13. [In Persian]
- Ahlfors, C.E., Wennberg, R.P., Ostrow, J.D. and Tiribelli, C. (2009). Unbound (Free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clinical Chemistry, 55(7): 1288-1299.
- Arboix, A., Garcia-Eroles, L., Oliveres, M., Targa, C., Balcells, M. and Massons, J. (2010). Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BioMedCentral the Open Access Publisher Neurology, 10(18): 1-11.
- Badyal, D.K. and Dadhich, A.P. (2001). Cytochrome P450 and drug interactions. Indian Journal of Pharmacology, 33(1): 248-259.
- Bayorh, M.A., Ganafa, A.A., Eatman, D., Walton, M. and Feuerstein, G.Z. (2005). Simvastatin and losartan enhance Feuerstein GZ. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt induced hypertension. American Journal of Hypertension, 18(11): 1496-1502.
- Bert, S., Gouyon, Y.B. and Semana, D.S. (2004). Calcium, sodium and potassium urinary excretion during the first five days of life in very preterm infants. Karger Journal Neonatology, 85(1): 37-41.
- Derakhshanfar, A., Bidadkosh, A. and Kazeminia, S. (2007). Vitamin E protection against gentamicin-induced nephrotoxicity in rats: a biochemical and histopathologic study. Iranian Journal of Veterinary Research, 20(3): 231-238. [In Persian]
- Esposito, E., Rinaldi, B., Mazzon, E., Donniacuo, M., Impellizzer, D., Paterniti, I., et al. (2012). Anti-inflammatory effect of simvastatin in an experiment model of spinal cord trauma: involvement of PPAR-α. Journal of Neuroinflammation, 26(9): 1-81.
- Ghosh, B., Sengupta, S., Bhattacharjee, B., Majumder, A. and Sarkar, S.B. (2004). Fenofibrate-induced myopathy. Neurology India, 52(2): 268-269.
- Jabbari, M., Rostami, Z., Jenabi, A., Shoolami, Z.L. and Mooraki, A. (2011). Simvastatin Ameliorates Gentamicin-Induced Renal Injury in Rats. Saudi Journal of Kidney Diseases and Transplantation, 22(6): 1181-1186.
- Krycer, J.R., Phan, L. and Brown, A.J. (2012). A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products. Biochemical Journal, 446(2): 191-201.
- Koh, K.K., Sakuma, I. and Quon, M.J. (2011). Differential metabolic effects of distinct statins. Atherosclerosis, 215(1): 1-8.
- Lefer, D.J., Scalia, R., Jones, S.P., Sharp, B.R., Hoffmeyer, M.R., Farvid, A.R., et al. (2001). HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB (Federation of American Societies for Experimental Biology) Journal, 15(8): 1454-1456.
- Lopez Novoa, J.M., Quiros, Y., Vicente, L., Morales, A.I. and Lopez-Hernandez, F.J. (2011). New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney International, 79(1): 33-45.
- Mooradian, A.D., Haas, M.J., Batejko, O., Hovsepyan, M. and Feman, S.S. (2005). Statins ameliorate endothelial barrier per- permeability changes in the cerebral tissue of strepto zotocin- induced diabetic rats. American Diabetes Association, 54(10): 2977-2982.
- Pastori, D., Polimeni, L., Baratta, F., Pani, A., Del Ben, M. and Angelico, F. (2015). The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease. Digestive and Liver Disease, 47(1): 4-11.
- Pound, E.M., Kang, J.X. and Leaf, A. (2001). Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. Journal of Lipid Research, 42(3): 346-351.
- Quiros, Y., Vicente-Vicente, L., Morales, A.I., López-Novoa, J.M. and López-Hernández, F.J. (2011). An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicological Sciences, 119(2): 245-256.
- Rahman, M., Shad, F. and Smith, M.C. (2012). Acute kidney injury: a guide to diagnosis and management. American Family Physician, 86(7): 631-639.
- Shekelle, P., Morton, C.S., Hardy, M., Coulter, I., Udani, J., Spar, M., et al. (2003). Effect of supplemental antioxidants vitamin C, vitamin E and coenzyme Q10 for the prevention and treatment of cardiovascular disease. Evidence Report/Technology Assessment, 86(6): 1-106.
- Shishehbor, M.H., Brennan, M.L., Aviles, R.J., Penn, M.S., Spreche, D.L., Hazen, S.L., et al. (2003). Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation, 108(4): 426-431.
- Tesfamariam, B., Frohlich, B.H. and Gregg, R.E. (1999). Differential effects of pravastatin, simvastatinand atorvastatin on Ca2+ release and vascular reactivity. Journal of Cardiovascular Pharmacology, 34(1): 95-101.
- Vaquero, M., Caballero, R., Gómez, R., Núñez, L., Tamargo, J. and Delpón, E. (2007). Effects of atorvastatin and simvastatin on atrial plateau currents. Journal of Molecular and Cellular Cardiology, 42(5): 931-945.
- Vaughan, C.J., Gotto, A.M. and Basson, C.T. (2000). The evolving role of statins in the management of atherosclerosis. Journal of the American College of Cardiology, 35(1): 1-10.
- Von Stechow, D., Fish, S., Yahalom, D., Bab, I., Chorev, M., Muller, R., et al. (2003). Does simvastatin stimulate boneformation in vivo. Digital Access to Scholarship at Harvard, 4(8): 1-8.
- Yagi, S., Akaike, M., Aihara, K., Iwase, T., Ishikawa, K., Yoshida, S., et al. (2011). Effect of low-dose (1 mg/day) pitavastatin on left ventricular diastolic function and albuminuria in patients with hyperlipidemia. AM (Ante Meridian) Journal of Cardiology, 107(11): 1644-1649.
|
